Laboratorium Farmaceutyczne Avenasp. z o.o.
Manufacture of pharmaceutical preparations
Overview
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Brak
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 80 days late).
- 202502/07/2026
- 202402/07/2025
- 202310/07/2024
- 202213/07/2023
- 202103/10/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Trademarks
Laboratorium Farmaceutyczne Avena holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 1994.
| Mark | Protected until | |
|---|---|---|
| AVENA | Jun 24, 2034 |
Authorized Representatives
Manner of representation
If a one-person management board of the company is appointed, the appointed member of the management board is authorised to represent the company individually; in all other cases, two members of the management board jointly or a member of the management board jointly with a commercial proxy are authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
10 1090 1896 0000 0005 0800 0029
66 1240 4533 1111 0011 3869 9319
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $7,534$7,534 |
Buildings and premises | $280K$279,957 |
Public aid
69 public aid cases recorded, with a total value of $39,729.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 4, 2023 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $976$976 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Mar 7, 2023 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $976$976 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych | |
| Jan 24, 2023 | Aid in the form of wage subsidies for the recruitment of workers with disabilities | $892$892 | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PoltregS.A. | $1,906,011.66 | poltreg.com | ||
| Przedsiębiorstwo Farmaceutyczne Sulphur Zdrój Eximsp. z o.o. | $1,592,037.83 | sulphur.com.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o. | $893,738.50 | lekinatury.pl | ||
| Human BiomeS.A. | $888,361.19 | human-biome.com | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl |
FAQ
Last updated: 2026-10-07